10.28.15
Here's to a slimmer Europe.
Acelity has released its Revolve fat processing system in the European Union. The product offers fast, efficient and secure fat tissue processing in a range of reconstructive procedures. Fat grafting involves harvesting and transferring adipose tissue or body fat from one area of the body to another. The technique is gaining in popularity with surgeons because it uses the patient’s own tissue to enhance volume.
The Revolve system is designed to yield rapid, reliable results in high-volume procedures through the use of a simple, closed system that controls critical variables in fat grafting. The single-use device can be placed in the sterile field to facilitate more efficient processing, filtering and transferring of a patient’s own (autologous) fat tissue, the company claims. It enables high-volume fat processing (up to 700ml lipoaspirate) in less than 10 minutes, offering the potential to reduce operating room procedure time.
“With this European launch, Acelity continues to set global benchmarks in bringing cutting edge technologies to patients and setting the bar for standard of care in fat grafting,” said Lesley Fronio, vice president and franchise leader of Breast Reconstruction and Fat Grafting at Acelity. “We continue adding to our portfolio of fat grafting products to provide clinicians with the tools they need to perform the most up-to-date procedures, efficiently and effectively.”
The Revolve system has been used in multiple fat grafting surgeries, though company executives did not provide a specific number. Revolve uses surgical mesh specifically designed to filter blood debris and fluid to attain clean and high quality adipose tissue for transfer. The device also has a proprietary “collagen string catcher,” which helps prevent clogging within syringe tips during adipose re-implantation and effectively enhances procedural speed and proficiency.
“Fat grafting shows tremendous promise for the future of plastic surgery, as it uses patients’ own fat cells instead of foreign material implants,” said Ash Mosahebi, Ph.D., MBBS, FRCS, FRCS consultant and Hon Senior Lecturer at Royal Free Hospital in London, United Kingdom. “The Revolve system helps clinicians efficiently process high volumes of fat tissue to produce quality natural fat product, ultimately helping patients achieve more natural-looking results.”
Acelity is a global wound care and regenerative medicine company created by uniting three companies: Kinetic Concepts, Inc., LifeCell Corporation and Systagenix Wound Management, Ltd. Headquartered in San Antonio, Texas, Acelity employs more than 5,500 people around the world.
Acelity has released its Revolve fat processing system in the European Union. The product offers fast, efficient and secure fat tissue processing in a range of reconstructive procedures. Fat grafting involves harvesting and transferring adipose tissue or body fat from one area of the body to another. The technique is gaining in popularity with surgeons because it uses the patient’s own tissue to enhance volume.
The Revolve system is designed to yield rapid, reliable results in high-volume procedures through the use of a simple, closed system that controls critical variables in fat grafting. The single-use device can be placed in the sterile field to facilitate more efficient processing, filtering and transferring of a patient’s own (autologous) fat tissue, the company claims. It enables high-volume fat processing (up to 700ml lipoaspirate) in less than 10 minutes, offering the potential to reduce operating room procedure time.
“With this European launch, Acelity continues to set global benchmarks in bringing cutting edge technologies to patients and setting the bar for standard of care in fat grafting,” said Lesley Fronio, vice president and franchise leader of Breast Reconstruction and Fat Grafting at Acelity. “We continue adding to our portfolio of fat grafting products to provide clinicians with the tools they need to perform the most up-to-date procedures, efficiently and effectively.”
The Revolve system has been used in multiple fat grafting surgeries, though company executives did not provide a specific number. Revolve uses surgical mesh specifically designed to filter blood debris and fluid to attain clean and high quality adipose tissue for transfer. The device also has a proprietary “collagen string catcher,” which helps prevent clogging within syringe tips during adipose re-implantation and effectively enhances procedural speed and proficiency.
“Fat grafting shows tremendous promise for the future of plastic surgery, as it uses patients’ own fat cells instead of foreign material implants,” said Ash Mosahebi, Ph.D., MBBS, FRCS, FRCS consultant and Hon Senior Lecturer at Royal Free Hospital in London, United Kingdom. “The Revolve system helps clinicians efficiently process high volumes of fat tissue to produce quality natural fat product, ultimately helping patients achieve more natural-looking results.”
Acelity is a global wound care and regenerative medicine company created by uniting three companies: Kinetic Concepts, Inc., LifeCell Corporation and Systagenix Wound Management, Ltd. Headquartered in San Antonio, Texas, Acelity employs more than 5,500 people around the world.